MAST (Medically Associated Science and Technology) Program released Episode 3 of Eating, Interrupted featuring Mark Pimentel discussing the immune system and autoimmune disease.
Published
Signal category
Presence & Recognition
Quote
“Episode 3 with you: What happens when your immune system gets it wrong?”
— Mark Pimentel|MAST (Medically Associated Science and Technology) Program team
Company
MAST (Medically Associated Science and Technology) Program
Cedars-Sinai’s MAST program develops innovative drugs and devices to diagnose and treat patients.
- Industry
- Research
- Location
- Los Angeles, US
- Company size
- 6 employees
The Medically Associated Science and Technology (MAST) Program at Cedars-Sinai has been focused on one goal: turning science into better care for patients. By studying the gut microbiome and how it affects digestive and metabolic health, MAST helps improve the way conditions like IBS, SIBO, and metabolic disease are understood, diagnosed, and treated. Our team brings together physicians, researchers, and innovators who start with real patient experiences and build practical solutions, from advanced diagnostic tools to new treatment approaches. At MAST, research isn’t just about discovery — it’s about helping patients feel better, faster, and with confidence in their care.
Founded 2018